Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Shire
With
Takeda Development Center Americas, Inc.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Voluntarily provide written, signed, and dated (personally or via a legally-authorized representative) informed consent/and assent as applicable to participate in the study. Expression of understanding and agreement by fully informed parent(s) or legal guardian is required to permit the investigator to enroll a child in this study. The choice of the terms parental consent or parental permission in different regions may reflect local legal/regulatory and ethical considerations.
Diagnosis of HAE Type I or Type II.
Ability to use a mobile device for data collection in the study.
You may not be if
Participation in any interventional clinical trial at the time of enrollment.
Unable to provide written, signed, and dated informed consent/assent.
Investigator believes that the participant is not a suitable candidate for the study.
Clareo Health | A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II in North America
